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ABSTRACT
Purpose: Mu¨llerian duct remnants (MDRs) are present in a male pseudohermaphroditic form
characterized by failure of the mu¨llerian duct to regress due to insufficient production or
peripheral action of mu¨llerian inhibiting substance. The MDR can be asymptomatic but it often
results in infections, stones and voiding troubles. Furthermore, it may develop into a neoplasm.
Therefore, surgery is mandatory for large MDRs and symptomatic patients. Laparoscopic re-
moval is described.
Materials and Methods: Six males were treated from February 1998 to February 2003. Age at
surgery was between 3 and 18 years (mean 8.6). All patients showed severe hypospadias and 2
had mixed gonadal dysgenesis with ambiguous genitalia. Three patients presented with urogen-
ital infections and all had a large MDR. Laparoscopic procedures, which were preceded by
cystoscopy, were performed using a 10 mm umbilical trocar for the camera and 3, 5 mm trocars
for instruments placed in the suprapubic region and iliac fossa bilaterally. The remnants were
ligated with endoscopic loops or an endoscopic GIA stapler and cut.
Results: Mean operative time was 2 hours. We noted no complications. In 2 cases there was
deferential ectopia and in another of mixed gonadal dysgenesis bilateral gonadectomy was
performed because of the risk of degeneration. Feeding started on postoperative day 1 and the
patients were discharged home on day 5. After a followup of 8 months to 4 years all boys were
healthy.
Conclusions: Multiple approaches are used in traditional surgery, often leading to complica-
tions. Laparoscopy improves the view, decreases surgical risk and operative time, avoids large
scars and allows more rapid hospital discharge.
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Mu¨llerian duct remnants (MDRs) presenting as mu¨llerian
duct cysts (MDCs), enlarged prostatic utricles (EPUs) or va-
gina masculina (VM) can arise from the posterior and bulbar
urethra due to failure of the fetal testis to suppress these
female structures, presumably as a consequence of an inap-
propriate or delayed secretion of testosterone and mu¨llerian
regression factor.1, 2 These abnormalities of the genitourinary
tract may be seen in normal boys rather than in those with
hypospadias and intersex disorders (mixed gonadal dysgen-
esis and true hermaphroditism).3 Although the embryoge-
netic difference between EPU and MDC is still controversial,
from a clinical point of view these entities are well defined.4
EPU is a tubular shaped structure communicating with the
urethra that is frequently observed in younger patients in
association with hypospadias, intersex disorders or other
anomalies (prune-belly syndrome, posterior urethral valves,
Downs syndrome and imperforate anus).1, 3, 5 EPUs are com-
monly identified while performing voiding cystourethrogra-
phy (VCU) or cystoscopy. When other mu¨llerian structures
(cervix, uterus or fallopian tubes) are present, this complex is
better defined as vagina masculina. On the other hand,
MDCs are round and located in the midline. Size is a few cm
to huge masses occupying the whole pelvis. They are often
associated with normal external genitalia and become symp-
tomatic later in life. They usually do not communicate with
the urethra and, thus, they are rarely discovered during VCU
or urethroscopy.4
EPUs and MDCs are frequently symptom-free but they
may also cause urinary problems, such as recurrent infec-
tions or epididymitis, irritative problems (frequency, dysuria
and urgency), obstructive problems (hesitance, a decreased
urinary flow rate, prolonged voiding, urinary retention and
stone formation) or less frequently terminal hematuria, ure-
thral discharge, perineal and abdominal pain, a palpable
mass, constipation, impotence, azoospermia and infertility.5
Furthermore, a small but significant number of reports de-
scribe the development of malignant carcinoma from MDRs.6
Several surgical techniques have been advocated to access
the retroprostatic space and remove MDRs. In 1994 the lapa-
roscopic approach to excise an MDC in a man was described,
preserving continence and potency.7 In 1998 we first success-
fully performed laparoscopic removal of VM in the pediatric
age group.8
We present our series of 6 boys with MDR who underwent
to laparoscopic ablation. Embryology, clinical presentation,
diagnostic evaluation and surgical management are dis-
cussed.
MATERIALS AND METHODS
Six boys with MDR 3 to 18 years old (mean age 8 years 6
months) were admitted to our department from February
1998 through February 2003 (see table). All except patient 4
had severe hypospadias. Patients 3 and 6 also presented with
mixed gonadal dysgenesis (MGD) and ambiguous genitalia.
Patient 1 had monolateral cryptorchidism associated with
“didymo-epididymal” dissociation and deferential ectopia,
and patient 4 had anorchia.
In patients 2 and 5 MDRs were represented by an EPU
(grade II according to Ikoma et al9), whereas in the others
VM with a hypoplastic uterus was present. In all cases the
MDR ended in the prostatic urethra. In patient 1 2 small
fallopian tubes and a vaginal septum were found in the
surgical specimen.Accepted for publication August 29, 2003.
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History was positive in 3 cases. Patients 1 and 4 had had
many episodes of monolateral epididymitis. Patient 5 with a
huge EPU presented with recurrent urinary infections unre-
sponsive to antibiotic therapy. In these 3 cases the diagnosis
of MDR was made by VCU, laparoscopy performed for uni-
lateral cryptorchidism and ultrasound (US), respectively. In
the latter patient VCU provided a false-negative result be-
cause of the narrow passage of the MDR into the urethra.
Three cases were asymptomatic. In patients 2 and 3 the
diagnosis was made after screening VCU performed to detect
hidden associated uropathies in patients with scrotal hypos-
padias (fig. 1). In patient 6 routine US at birth showed a
hypoechogenic cystic-like structure located in the retropros-
tatic space, which was correctly interpreted as an MDR. VCU
was negative. Briefly, US was diagnostic in 2 of the 6 cases
(66.6% false-negative findings) and VCU was diagnostic in 4.
Peripheral blood lymphocyte karyotyping confirmed a nor-
mal male 46XY configuration in all except patient 3, who had
MGD and incomplete masculinization with 46XY-45XO
mosaicism. This patient also underwent magnetic resonance
imaging to provide better anatomical definition of the inter-
nal genitalia and plan the correct surgical strategy. Treat-
ment was laparoscopic removal in all boys.
Preliminary cystoscopy and MDR endoscopy were always
performed to evaluate the shape, size and exact location of
the communication between the MDR and the urethra. MDR
endoscopy was often repeated during laparoscopic removal to
use the endoscope light as a guide in the dissection of the
retroprostatic space. It was particularly useful for EPUs in
which the dome did not extend out from the peritoneal re-
flection (fig. 2).
Four trocar ports were used. A 10 mm trocar was placed for
the 0-degree camera just below the umbilical scar. An addi-
tional 3, 5 mm trocars were inserted under direct vision in
the suprapubic region, and in the left and right iliac fossae,
respectively.
After pneumoperitoneum was achieved (11 per minute and
10 mm Hg) and the MDR was localized the peritoneal reflec-
tion coating the fundus of the EPU or surrounding the body
of the hypoplastic uterus was incised. The MDR was grasped
with forceps introduced by the suprapubic trocar and care-
fully dissected free of the surrounding tissues of the ret-
rovesical space with another 2 instruments introduced
through the iliac fossa trocars. Particular attention was
given to avoid injury to the bladder neck, urethra, rectum,
ureters, vas deferens, prostate and seminal vesicles. The use
Mu¨llerian duct remnant treated by laparoscopic removal
Pt
No. Clinical Features Previous Surgery Symptoms Diagnostic Evaluations
Age at
Surgery
(yrs)
Surgical Procedure
1 VM, vaginal septum, scro-
tal hypospadias, lt cryp-
torchidism, D-E dissoci-
ation, deferential
ectopia
Urethroplasty, or-
chiopexy
Recurrent epidid-
ymitis
Neg US, pos VUCG 15 Laparoscopic removal
2 EPU, hypoplastic, lt fallo-
pian tube, scrotal hypos-
padias, deferential ecto-
pia  atresia
None None Neg US, pos VUCG 3 Laparoscopic removal
3 VM, MGD, 46XY-45XO
mosaicism, scrotal hypo-
spadias, D-E dissocia-
tion, rt testis, lt gonadal
streak
Rt testis biopsy, lt
streak removal
done elsewhere,
urethroplasty
None Neg US, pos VUCG  neg ex-
cretory urography done else-
where, pos magnetic reso-
nance imaging
18 Laparoscopic re-
moval, lt streak
gonadectomy
4 VM, rt cryptorchidism, lt
inguinal hernia
Diagnostic laparos-
copy (blind end-
ing), lt hernio-
plasty
Lt epididymitis Neg US, pos VUCG 4 Laparoscopic removal
5 EPU, scrotal hypospadias,
post-urethroplasty ste-
nosis  fistula
Urethroplasty, ure-
thral dilations,
urethroplasty re-
vision
Recurrent urinary
infections
Pos US, neg VUCG 8 Laparoscopic removal
6 VM, MGD, scrotal hypos-
padias, rt cryptorchid-
ism, lt gonadal streak,
post-urethroplasty fis-
tula
Diagnostic laparos-
copy (VM, hypo-
plastic rt testis 
lt streak on diag-
nostic laparoscopy
None Pos US, neg VUCG 4 Laparoscopic re-
moval, bilat gonad-
ectomy, testicular
tissue cryopreser-
vation
Disease-free outcome in all patients.
FIG. 1. MDR detected by routine VCUG
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of a monopolar hook, bipolar coagulation and harmonic scal-
pel allowed completely bloodless dissection of all adhesions
without clips and ligatures. After it was completely dissected
the MDR neck was secured with 2 endoscopic loops or an
endoscopic GIA stapler in older patients and resected just
above its junction with the urethra (fig. 3). The specimen was
removed through the 10 mm port.
A bladder Foley catheter was positioned before the end of
the procedure.
RESULTS
In our experience mean operative time was 1 hour 53
minutes (range 1 hour 12 minutes to 3 hours 54 minutes). No
major complications were recorded.
Deferential ectopia, in which the vas is joined with the
vaginal pouch or hypoplastic uterus, was found in patients 1
and 2, and associated with didymo-epididymal dissociation
and histologically confirmed deferential atresia, respectively.
In each case the vasa was transected. Patients 3 and 6 with
MGD and ambiguous external genitalia had VM with a hy-
poplastic uterus and fallopian tubes connected with the pos-
terior urethra. Moreover, a dystrophic testis dissociated from
the epidydimis was found on 1 side and a gonadal streak was
noted on the other side. In patient 3 the testis was normally
located in the ipsilateral hemiscrotum. In this patient par-
ents refused consent for right orchiectomy despite the risk of
neoplastic evolution. Close long-term clinical and ultrasono-
graphic followup was planned. In contrast, in patient 6 with
MGD bilateral gonadectomy was performed. To provide the
child with a chance of reproduction using new assisted repro-
ductive techniques cryoconservation of testicular tissue was
done.
Histological examination of the removed testis showed a
poor germinal component with focal signs of spermatogenesis
and diffused peritubular fibrosis.
Patients resumed free oral fluid intake on the day of the
laparoscopic procedure and they were able to ingest food on
postoperative day 1. Postoperative discomfort, which was
generally limited to days 1 and 2, was easily controlled by the
administration of nonsteroidal analgesics on demand. Con-
valescence was uneventful and patients were discharged
home on postoperative day 5 after Foley catheter removal
and the exclusion of micturition problems.
All patients are well and free from urogenital tract infec-
tions, voiding dysfunctions or urinary incontinence at a fol-
lowup of from 6 months to 4 years. Because symptoms were
completely absent, no further x-rays were performed.
DISCUSSION
During normal embryogenesis at about 6 weeks of devel-
opment the paramesonephric or mu¨llerian ducts appear bi-
laterally beside the wolffian duct and grow caudal, fusing
together in the midline to form the uterovaginal cord. By
month 4 of gestation they join the urogenital sinus in asso-
ciation with epithelial proliferation, called the mu¨llerian tu-
bercle.
In the female embryo these primordial structures form the
tubes, uterus and the distal 4/5 of the vagina, which at its
caudal end originates from the urogenital sinus.
In the male embryo the mu¨llerian ducts regress under the
effect of mu¨llerian regression factor, a nonsteroidal hormone
produced by Sertoli’s cells in the testis during a short critical
period at the end of the undifferentiated stage (weeks 9 to
10). After complete male sexual development only the ce-
phalic and caudal ends of the mu¨llerian ducts persist, as the
appendix testis and a part of the prostatic utricle, respective-
ly.1, 9
Differentiation of the urogenital sinus and external geni-
talia is a complex phenomenon that develops from weeks 9 to
16 of gestation and depends on circulating levels of testos-
terone and its derivative dihydrotestosterone.1
Glenister reported that the prostatic utricle has clearly a
mixed origin.10 Its cranial portion is from the mu¨llerian duct,
while the caudal portion arises from the urogenital sinus.
Because of this mixed origin, a hormonal imbalance in mu¨l-
lerian regression factor and testosterone secretion or the
MRF responsiveness of target tissues during the short criti-
cal period could influence the formation of the prostatic utri-
cle. Therefore, anomalies can result from incomplete regres-
sion of the mu¨llerian ducts or incomplete androgen mediated
closure of the urogenital sinus.1, 2
US may demonstrate cystic or elongated formation located
in the retrovesical space between the urethra, bladder neck
and rectum. To our knowledge no experience with transrectal
FIG. 2. Laparoscopic view of MDR under light of inserted
cystoscope.
FIG. 3. Position of endo-loop down to MDR neck
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US has been reported in the pediatric age group. VCU can
show the EPU and its location, size and communication with
the urethra. Magnetic resonance imaging or computerized
tomography could be helpful in cases of persistent diagnostic
problems after US and VCU.
In our experience the management of MDR has been based
on clinical presentation, size, relationship with adjacent
structures and radiological classification. Conservative treat-
ment was adopted in grades 0 and 1 uncomplicated EPU9 in
the absence of other mu¨llerian structures (ie a vagina or
uterus) or lower urinary tract anomalies. In these patients
we consider that careful followup is advisable based on peri-
odic clinical examinations and US, if necessary integrated by
VCU and urethroscopy. The development of persistent clini-
cal symptoms, progressive MDR enlargement or other com-
plications indicate a change from medical to surgical treat-
ment. In contrast, surgery is mandatory in grade 2 or 3 EPU,
which is unresponsive to medical treatment, and in all cases
of VM because it may cause psychological disturbances in
older patients. Sometimes MDR can hamper bladder cathe-
terization by providing a preferential route to the urinary
catheter. Thus, a further indication to remove MDR surgi-
cally is the difficulty of catheterizing a child with neurologic
bladder who requires clean intermittent catheterization.11
Several surgical techniques have been proposed to treat
MDR, including a perineal, retropubic or suprapubic ex-
travesical, transvesical transtrigonal, transperitoneal, poste-
rior sagittal transanorectal, anterior sagittal transanorectal
and posterior perirectal or pararectal approaches.
The perineal approach12 may be technically extremely dif-
ficult, especially in young children, since the small size of the
perineum may not permit adequate exposure of the recto-
prostatic space. When the EPU is large, it can endanger the
rectum, external sphincter and branches of the pelvic plexus
innervating the corpora cavernosa and rectum. For this rea-
son it has been abandoned by most surgeons.
The retropubic or suprapubic extravesical method requires
incomplete or complicated excision often entailing the re-
moval of 1 or the 2 seminal vesicles, the vasa and portions of
the prostate. Recently Ikoma et al reported a success rate of
100% with this approach alone or associated with the peri-
neal approach.12
The transvesical transtrigonal approach was proposed by
Monfort due to excellent exposure of the retrovesical space
after posterior splitting of the bladder wall.13 The MDR can
be easily identified as well as the vasa, which can be sepa-
rated and even saved when it ends normally. The disadvan-
tages of this technique are the need for prolonged urinary
drainage to allow bladder healing and occasional transient
vesicoureteral reflux in the postoperative period. Monfort
also performed antireflux vasocystostomy in 7 patients with
deferential ectopia to preserve testicular function due to the
possibility of collecting spermatozoa by urine ultracentrifu-
gation.14 Ikoma et al proposed reimplantation of the severed
vas deferens into the posterior urethra or, if the vas was too
short, vasovasostomy on the contralateral vas.12 The effec-
tiveness of deferential preservation must be investigated,
especially in cases of mixed gonadal dysgenesis since no proof
of fertility has been reported in these patients to date.4, 15 In
our 2 cases of an ectopic vasa entering the MDR we did not
perform vesical or urethral reimplantation because of
didymo-epdidymal dissociation and deferential atresia, re-
spectively. At any rate the laparoscopic approach does not
allow any kind of vasal reimplantation in any case.
The transperitoneal approach was proposed for large
MDRs and especially for VM, in which a uterine structure
emerges from the peritoneal fold. In all other cases of a small
MDR this invasive approach does not allow easy dissection of
the rectovesical space, causing a high risk of damage to the
nerves, urethra, ureters and vasa. Moreover, opening the
peritoneum can create adhesions and consequently bowel
obstruction.16
The posterior sagittal transanorectal approach, which was
proposed by Siegel et al,17 provides extensive exposure of the
rectourethral space by splitting the posterior and anterior
rectal walls without interfering with fecal continence. Nev-
ertheless, it requires meticulous bowel preparation and pa-
tients must fast for a week postoperatively. Moreover, al-
though with current methods of bowel preparation and
antibiotic therapy it is possible to avoid colostomy, when
bowel preparation is unsatisfying, temporary colostomy may
be required to decrease the risk of an infectious complication,
which in this area could compromise fecal continence.
The anterior sagittal transanorectal approach18 provides
similar excellent surgical exposure of the posterior urethra
and retrovesical region by splitting only the anterior rectal
wall and saving the elevator anus, posterior part of the mus-
cle complex and external sphincter. Temporary colostomy is
indicated if bowel preparation is not excellent.
A posterior pararectal or perirectal approach with rectal
retraction has been proposed to avoid colostomy.19, 20 Al-
though Pinter et al observed that this procedure does not
impair fecal continence,19 we believe that rectal mobilization
causes rectal denervation by destruction of the reflex arc
between the rectum and striated muscle sphincters.18 More-
over, in cases of a huge MDR, this approach is unsuitable
because the anus limits the distal extent of incision.
All of these procedures are often technically challenging
and require prolonged hospitalization. Furthermore, they
carry the potential risk of complications, such as infection,
incontinence and impotence.5
For these reasons endoscopic treatment was introduced by
many groups with encouraging results but several limita-
tions. Recently Husmann and Allen reported their experience
with endoscopic electrofulguration to treat EPU or residual
rectourethral fistulas with a good success rate and minimal
perioperative morbidity.11, 15 Nevertheless, they stated that
this procedure is not adequate for VM because it does not
remove the MDR, rather causing its obliteration, while there
is a risk of injuring the adjacent ejaculatory ducts by trans-
mitted electrical hazard.11
Laparoscopy obviates these disadvantages because it pro-
vides an optimal view due to imaging magnification. It per-
mits fine dissection of the MDR with excellent exposition of
all anatomical structures with a minimal access to the peri-
toneal cavity and a low incidence of postoperative adhesions.
In 1994 McDougall et al described laparoscopic excision of
a 7 cm MDC in a 48-year-old man with the preservation of
continence and potency.7 They completely fulgurated the re-
maining cystic internal mucosa, which was less than 1 cm, to
destroy any residual epithelium and achieve complete oblit-
eration of the cyst cavity.
We agree with Husmann and Allen that endoscopic elec-
trofulguration does not completely remove the cystic wall or
eliminate the chance of neoplastic degeneration from the
scarified remnant.11 Moreover, in young children and in the
hands of a skilled endoscopist the endoscopic procedure is not
easy and it is potentially risky. Therefore, when a few mm of
residual tissue are left in place, we prefer to adopt a precise
clinical, ultrasonographic and eventually radiological or en-
doscopic program of long-term surveillance rather than risk-
ing iatrogenic damage to the important structures of the
retrourethral space.
In our experience laparoscopy allowed us to perform effec-
tive dissection of the MDR from the retrovesical space be-
cause it provides clear identification of the ureters, seminal
vesicle, urethra and bladder neck which, thus, can be gently
retracted and preserved.
On the other hand, laparoscopy does not resolve the prob-
lem of the abnormal connection between the vas deferens and
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the MDR because today it is still impossible to perform lapa-
roscopic vasal reimplantation in the bladder or in urethra.
In conclusion, when compared with other surgical ap-
proaches, in the hands of a careful, trained surgeon the
laparoscopic approach provides minimally invasive access to
the retrovesical space, improving the view, decreasing the
incidence of complications and operative time, and avoiding
large scars.
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